Listening First: How to Start, Guide, and Personalize Menopause Conversations with Patient

In this episode, 'Listening First: How to Start, Guide, and Personalize Menopause Conversations with Patients,' the panelists explore the following questions:

1. What does a 'symptom-based conversation' look like with patients, and how is it different from a mechanism-first or guideline-first conversation?
2. What signals might inform a pharmacist that a patient is worth flagging or counseling over their symptoms?
3. Are there questions pharmacists or clinicians can ask to help gauge patient preferences around hormones vs. non-hormonal options?
4. How do you set expectations around onset of effect during that first prescription?

The panelists examined why a symptom-first approach is the most effective way to open conversations with menopausal patients, emphasizing that starting with mechanisms or guidelines often creates confusion or triggers fear, whereas asking patients directly what is most disrupting their quality of life, and what they hope treatment will change, allows clinicians and pharmacists to personalize recommendations and give patients a meaningful sense of agency in their own care. The discussion highlighted that menopause symptoms frequently present in clusters and in indirect ways, such as complaints about sleep, brain fog, mood, or sexual discomfort rather than hot flashes, and that pharmacists are uniquely positioned to recognize these signals at the counter, in the OTC aisle, or during medication consultations, making active listening and open-ended questioning essential clinical skills for this patient population. The panelists also explored how to navigate patient biases and fears around hormone therapy, with the consensus being that leading with a thorough, personalized risk-benefit assessment builds the trust necessary for patients to be genuinely receptive to the full menu of treatment options, hormonal and non-hormonal alike.

Throughout the conversation, the experts provide a comprehensive reflection on the field and the factors that may shape how clinicians approach care moving forward.

The next episode in this series, 'The Pharmacist as a Menopause Ally: Expanding the Role Beyond the Prescription,' features the panelists advancing their conversation on vasomotor symptoms and menopause and focusing on the pharmacist's evolving role in the long-term management of VMS, from validating patient experiences and bridging fragmented care to serving as a trusted community access point and collaborative partner in the broader menopause care team.